Introduction
Hyponatremia is a common medical problem, occasionally occurring as a result of adrenal insuffi ciencyprimary or secondary. In the latter case, treatment with glucocorticoids may lead to rapid correction of hyponatremia with attendant complications. We report such a case below and discuss implications for treatment.
Lasheen/Doi/Al-Shoumer Med Princ Pract 2005;14:115-117 116 7.1 mmol/l). At this point, serum and urine osmolality were 217 and 499 mosm/kg, respectively, and spot urine sodium was 22 mmol/l. He had an SIADH-like picture and was started empirically on dexamethasone (4 mg t.d.s.) [1] because of the suspicion of pituitary apoplexy and adrenal insuffi ciency. He only received 1 liter of normal saline per day for the fi rst 3 days and oral fl uid intake was restricted to 750 ml per day. Random cortisol and baseline thyroid function were requested prior to starting therapy.
Over the next 48 h he was relatively stable, urea and creatinine levels remained within normal range (urea 6.2 mmol/l, creatinine 114 m/l) but the urine output was markedly increased and he passed 4 liters of urine on the second day and 2.8 liters on the third day. On the third day of admission, he became more confused with dystonic posturing of all four limbs. There was no lateralizing neurologic defi cit and he had no extraocular muscle defi cit or visual signs. In the preceding 48 h, his serum sodium had risen by 30 mmol/l (15 mmol/day) mainly due to a diuresis of 5 liters/day, presumably corticosteroid-induced. From the third day of admission he kept on going in and out of the acute confusional state but dystonia persisted. At times he became extremely agitated and violent while at other times he was able to communicate, albeit with dysarthria. He could also walk with assistance. However, he retained urine, and had to be kept catheterized.
His hormone profi le subsequently was available: cortisol 111 nmol/l (normal 1 550), free T 3 2.8 pmol/l (normal 3.3-7.2), free T 4 10.4 pmol/l (normal 11-24), TSH 0.2 mU/l (normal 0.3-5), testosterone 1.3 nmol/l (normal 8-35) and IGF-1 4.7 nmol/l (normal 1 10). He then had a brain and pituitary MRI and was found to have a homogeneously enhancing pituitary macroadenoma with suprasellar extension but no compression of either lateral structures or of the optic chiasma ( fi g. 1 ). There was no MRI evidence of hemorrhage or infarction. There were hyperintense lesions on T 2 -weighted images within the basal ganglia ( fi g. 2 ). Electroencephalogram showed diffuse slowing and low voltage waves.
In retrospect, he was diagnosed to have myelinolysis as a result of glucocorticoid-induced overtly rapid sodium correction in the presence of baseline panhypopituitarism. The differential had been pituitary apoplexy, but this was dismissed after the imaging and clinical picture became clear. He was tapered to oral doses of hydrocortisone and started on thyroxine and remained free of electrolyte disturbances from day 3 of admission. He was transferred to neurosurgical follow-up on day 10.
Discussion
Hyponatremia could be the predominant presenting feature of adrenal insuffi ciency secondary to hypopituitarism. The pitfall of entertaining such a diagnosis is empiric glucocorticoid therapy and if this leads to rapid correction of hyponatremia, as in this case, myelinolysis as a neurologic complication can occur. It is therefore prudent that the severity of symptoms be considered in therapeutic decision-making. In adrenal disease with chronic hyponatremia, even adjunct treatment such as saline infusions are dangerous and are usually not needed if patients are asymptomatic [2] . It is important therefore that if a patient is clinically stable, even very low sodium level should not disturb the clinician and attempts to replace glucocorticoids should be approached very cautiously. Myelinolysis has been reported only once previously in a patient with hyponatremia in empty sella syndrome after substitution of glucocorticoids [3] . Ultimately, the patient, not the laboratory result, should receive treatment.
What then can we do in such situations? The answer is not clear, as withholding glucocorticoids is not free of complications. We therefore advocate, in retrospect, that the lowest possible dose of glucocorticoids should be used and serum sodium levels must be closely monitored because of the unexpected speed with which it may increase even with careful glucocorticoid titration. If this occurs, relowering the serum sodium may be worthwhile using 5% dextrose infusions or even giving dDAVP [2] . It has been suggested that the rate of correction should be kept below 10 mmol/l during a 24-hour period [4] , if possible. However, in one report of 14 cases of human myelinolysis after correction of hyponatremia [5] , it was found that in 21% of the patients, correction had been done in a fashion consistent with the so-called safe guidelines. Thus, it may be impossible to defi ne a level of correction that is always completely free of risk [4] . In our patient the cortisol replacement rapidly shut off antidiuretic hormone release (resulting in polyuria) and contributed to the rise in the serum sodium that ultimately resulted in myelinolysis. It is worthwhile to point out that the rate of rise of plasma sodium concentration is slower in patients with primary adrenal insuffi ciency in whom volume depletion due to aldosterone defi ciency contributes to the hyponatremia. Hence, patients at real risk are those with secondary adrenal insuffi ciency.
Myelinolysis, as a consequence of rapid correction of hyponatremia is also known to affect extrapontine brain areas and this occurs in 10% of patients and often affects the basal ganglia, mainly the caudate and putamen [6] . Our patient developed affective changes and dystonia but did not have the classic symptoms of myelinolysis (spastic quadriparesis and pseudobulbar palsy refl ecting damage to the corticospinal and corticobulbar tracts) that occur in more than 90% of these patients [5] and extrapontine myelinolysis was suspected since he had dystonia [5] .
Brain imaging, the most useful diagnostic test, confi rmed this suspicion. Computed tomography (CT) usually shows central pontine and extrapontine lesions as symmetrical areas of hypodensity [7] but MRI is more sensitive; lesions appear hyperintense on T 2 -weighted images and hypointense on T 1 -weighted images [8] . In our patient, MRI showed hyperintense lesions at the caudate nucleus ( fi g. 2 ). Because myelinolytic lesions may not be apparent on scans within the fi rst 2 weeks of illness, a later scan may be necessary to confi rm the diagnosis [5] . Indeed the initial CT in this patient was negative.
Medications aimed at alleviating symptoms of myelinolysis such as depression, psychosis or parkinsonism may be effective, but myelinolysis cannot be specifi cally treated. Corticosteroids do not appear to be effective [5] . Preliminary data from studies in animals suggest that relowering serum sodium in the initial hours and days after rapid correction may be benefi cial [9] . But it was not known whether or not this strategy would have been safe or effective in our patient. The outcome of patients with myelinolysis varies; some die and others recover completely. Many patients improve gradually or only partially [4] . It is therefore likely that our patient might improve, albeit gradually.
Conclusion
This case illustrated the problems associated with empiric glucocorticoid treatment of suspected hypopituitarism and the need to use minimum dose of glucocorticoids (1 mg t.d.s. of dexamethasone) with close monitoring of serum sodium, otherwise, uncontrolled correction of sodium can lead to potentially fatal consequences as noted here. Adjunct treatment of hyponatremia, such as saline, is not recommended in such cases. However, if the blood pressure does not respond to dexamethasone, only then would judicious use of saline be considered.
